oncology

Singapore Medical Group announces $50 mil share purchase from existing shareholder CHA

SINGAPORE (Feb 20): Singapore Medical Group (SMG) says its 6.86% shareholder CHA Healthcare Singapore (CHAS) is increasing its stake in the group to 24.13% by purchasing existing shares from certain SMG shareholders via a $50 million investment.  

This comes after the group called for a trading halt following a 4.4% surge in its share price to 47 cents within the first three hours of trading today.

Clearbridge BioMedics receives $6.6 mil in pre-IPO funding ahead of targeted 4Q launch

SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.

The company expects to launch its IPO in 4Q18.

In a Thursday announcement, the clinical stage cancer diagnostics company says it intends to use its latest round of funds for business expansion, technology development, talent recruitment and IPO-related expenses to develop end-to-end cancer diagnostic tests.

Be informed of the stories that matter